LIDODERM Drug Patent Profile

✉ Email this page to a colleague

When do Lidoderm patents expire, and when can generic versions of Lidoderm launch?

Lidoderm is a drug marketed by Teikoku Pharma Usa and is included in one NDA.

The generic ingredient in LIDODERM is lidocaine. There are twenty-nine drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the lidocaine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lidoderm

A generic version of LIDODERM was approved as lidocaine by ACTAVIS LABS UT INC on August 23^rd, 2012.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for LIDODERM?
What are the global sales for LIDODERM?
What is Average Wholesale Price for LIDODERM?

Summary for LIDODERM

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	12
Raw Ingredient (Bulk) Api Vendors:	131
Clinical Trials:	22
Patent Applications:	6,002
Drug Prices:	Drug price information for LIDODERM
What excipients (inactive ingredients) are in LIDODERM?	LIDODERM excipients list
DailyMed Link:	LIDODERM at DailyMed

Drug patent expirations by year for LIDODERM

Recent Clinical Trials for LIDODERM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Long Island University	Phase 4
University of Iowa	Phase 4
Nicole K Brogden	Phase 4

See all LIDODERM clinical trials

Pharmacology for LIDODERM

Drug Class	Amide Local Anesthetic Antiarrhythmic
Physiological Effect	Local Anesthesia

Paragraph IV (Patent) Challenges for LIDODERM

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
LIDODERM	Topical Patch	lidocaine	5%	020612	1	2009-11-13

US Patents and Regulatory Information for LIDODERM

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teikoku Pharma Usa	LIDODERM	lidocaine	PATCH;TOPICAL	020612-001	Mar 19, 1999	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for LIDODERM

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teikoku Pharma Usa	LIDODERM	lidocaine	PATCH;TOPICAL	020612-001	Mar 19, 1999	⤷ Sign Up	⤷ Sign Up
Teikoku Pharma Usa	LIDODERM	lidocaine	PATCH;TOPICAL	020612-001	Mar 19, 1999	⤷ Sign Up	⤷ Sign Up
Teikoku Pharma Usa	LIDODERM	lidocaine	PATCH;TOPICAL	020612-001	Mar 19, 1999	⤷ Sign Up	⤷ Sign Up
Teikoku Pharma Usa	LIDODERM	lidocaine	PATCH;TOPICAL	020612-001	Mar 19, 1999	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for LIDODERM

See the table below for patents covering LIDODERM around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Canada	2096744		⤷ Sign Up
European Patent Office	0565673	PROCEDE POUR AMELIORER UNE HUILE GLYCEROLYSEE (METHOD FOR IMPROVING A GLYCEROLYZED OIL)	⤷ Sign Up
Germany	69433859		⤷ Sign Up
Norway	951217		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration